Valley National Advisers’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-50
Closed -$1K – 990
2023
Q1
$1K Hold
50
– – ﹤0.01% 831
2022
Q4
$0 Hold
50
– – ﹤0.01% 939
2022
Q3
$0 Hold
50
– – ﹤0.01% 966
2022
Q2
$0 Hold
50
– – ﹤0.01% 948
2022
Q1
$1K Hold
50
– – ﹤0.01% 856
2021
Q4
$2K Hold
50
– – ﹤0.01% 799
2021
Q3
$2K Hold
50
– – ﹤0.01% 775
2021
Q2
$2K Hold
50
– – ﹤0.01% 791
2021
Q1
$2K Buy
+50
New +$2.6K ﹤0.01% 739

Other funds holding NEO

Valley National Advisers's NEO Position: Q2 2023 in Review

Valley National Advisers sold out of NeoGenomics (NEO) in Q2 2023, closing a stake of 50 shares — an estimated $1K sold.

Valley National Advisers first reported a position in NEO in Q1 2021 and held it in 9 quarters. The position peaked at $2K in Q4 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2023.

  • Valley National Advisers reported no remaining NeoGenomics position as of Q2 2023 after selling out during the quarter.
  • Valley National Advisers sold 50 NeoGenomics shares in Q2 2023, an estimated $1K.
  • Valley National Advisers first reported a position in NeoGenomics in Q1 2021 and held it in 9 quarters.
  • Valley National Advisers's NeoGenomics position peaked at $2K in Q4 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2023.

Based on Valley National Advisers's 13F filing for Q2 2023, filed 31 Jul 2023.